Key result
Endothelin A-receptor antagonism increases coronary blood flow and dilates distal coronary arterial segments, but may decrease collateral blood flow and perfusion of ischemic myocardium.
Endothelin A-receptor blockade increases coronary blood flow and decreases vascular resistance, but may reduce collateral perfusion to ischemic myocardium via a coronary steal phenomenon.
Answers are grounded in this paper and cite their sources.
May risk coronary steal in collateral-dependent myocardium; leaves open net ischemic effects of endothelin A antagonism.
We review the role of endothelin (ET) A-receptors (R) on the coronary circulation. ET-1 maintains the normal coronary artery tone. ET-1 plasma levels are increased during and after coronary angioplasty and this increase is related to myocardial ischaemia rather than to mechanical artery injury. ETAR antagonists inhibit coronary artery vasoconstriction induced by ET release after coronary angioplasty in humans. ET promotes neointimal formation and ETAR antagonism has been shown to inhibit restenosis after angioplasty in the animal model but not in humans. ETAR blockade increases coronary blood flow, dilates distal coronary arterial segments and decreases coronary vascular resistance. Coronary collaterals are less sensitive than other coronary vessels to ET-1. ETAR blockade decreases collateral blood flow and, consequently, perfusion of the ischemic myocardium.
No takes yet. Share an insight, caveat, or question.
Polymeropoulos et al. (2013) conducted a review in Coronary artery disease. Endothelin A-receptor antagonists was evaluated. Endothelin A-receptor antagonism increases coronary blood flow and dilates distal coronary arterial segments, but may decrease collateral blood flow and perfusion of ischemic myocardium.
Synapse has enriched 10 related papers. Consider them for comparative context: